首页> 美国卫生研究院文献>American Journal of Physiology - Renal Physiology >ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI
【2h】

ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI

机译:ATP通过P2X7受体激活诱导肾近端小管细胞中的PAD4加剧缺血性AKI

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We previously demonstrated that renal tubular peptidylarginine deiminase-4 (PAD4) is induced after ischemia-reperfusion (IR) injury and this induction of PAD4 exacerbates ischemic acute kidney injury (AKI) by promoting renal tubular inflammation and neutrophil infiltration. However, the mechanisms of renal tubular PAD4 induction after IR remain unknown. Here, we tested the hypothesis that ATP, a proinflammatory danger-associated molecular pattern (DAMP) ligand released from necrotic cells after IR injury, induces renal tubular PAD4 and exacerbates ischemic AKI via P2 purinergic receptor activation. ATP as well as ATPγS (a nonmetabolizable ATP analog) induced PAD4 mRNA, protein, and activity in human and mouse renal proximal tubule cells. Supporting the hypothesis that ATP induces renal tubular PAD4 via P2X7 receptor activation, A804598 (a selective P2X7 receptor antagonist) blocked the ATP-mediated induction of renal tubular PAD4 whereas BzATP (a selective P2X7 receptor agonist) mimicked the effects of ATP by inducing renal tubular PAD4 expression and activity. Moreover, ATP-mediated calcium influx in renal proximal tubule cells was blocked by A804598 and was mimicked by BzATP. P2X7 activation by BzATP also induced PAD4 expression and activity in mouse kidney in vivo. Finally, supporting a critical role for PAD4 in P2X7-mediated exacerbation of renal injury, BzATP exacerbated ischemic AKI in PAD4 wild-type mice but not in PAD4-deficient mice. Taken together, our studies show that ATP induces renal tubular PAD4 via P2X7 receptor activation to exacerbate renal tubular inflammation and injury after IR.
机译:我们先前证明了肾小管肽基精氨酸脱亚氨酶-4(PAD4)在缺血再灌注(IR)损伤后被诱导,并且这种PAD4的诱导通过促进肾小管炎症和中性粒细胞浸润而加重了缺血性急性肾损伤(AKI)。然而,IR后肾小管PAD4诱导的机制仍然未知。在这里,我们测试了一种假设,即ATP是IR损伤后从坏死细胞释放的促炎危险相关分子模式(DAMP)配体,它诱导肾小管PAD4并通过P2嘌呤能受体激活加剧缺血性AKI。 ATP和ATPγS(不可代谢的ATP类似物)在人和小鼠肾近端小管细胞中诱导PAD4 mRNA,蛋白质和活性。支持ATP通过P2X7受体激活诱导肾小管PAD4的假说,A804598(选择性P2X7受体拮抗剂)阻断了ATP介导的肾小管PAD4诱导,而BzATP(选择性P2X7受体激动剂)通过诱导肾小管模仿了ATP的作用。 PAD4的表达和活性。此外,ATP介导的肾近端小管细胞钙流入被A804598阻断,并被BzATP模仿。 BzATP激活的P2X7在体内还诱导了小鼠肾脏中PAD4的表达和活性。最后,支持PAD4在P2X7介导的肾损伤加重中的关键作用,BzATP在PAD4野生型小鼠中加剧了缺血性AKI,但在PAD4缺陷型小鼠中却没有。两者合计,我们的研究表明,ATP通过P2X7受体激活诱导肾小管PAD4,从而加剧IR后的肾小管炎症和损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号